1 – 19 of 19
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cyclosporine as Therapy for Traumatic Brain Injury
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
(
- Contribution to journal › Article
- 2018
-
Mark
The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Pancreatic Ductal Adenocarcinoma : Current and Evolving Therapies
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Praktische Anwendung der Levodopa-Pumpe
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer
2015) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33(18). p.2122-2123(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Developing stem cell therapies for Parkinson's disease : waiting until the time is right
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin is present in neuronal grafts in Huntington disease patients
(
- Contribution to journal › Article
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
- 2011
-
Mark
The role of RANK-ligand inhibition in cancer : the story of denosumab
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias
(
- Contribution to journal › Article
- 2005
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
- 2003
-
Mark
Tissue engineering of cartilage: do we need it, can we do it, is it good and can we prove it? : do we need it, can we do it, is it good and can we prove it?
(
- Contribution to journal › Article
- 2000
-
Mark
Neural tissue xenotransplantation : What Is Needed Prior to Clinical Trials in Parkinson’s Disease?
(
- Contribution to journal › Article
- 1999
-
Mark
The case for neural tissue transplantation as a treatment for Parkinson's disease
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP) : mechanisms of action
(
- Contribution to journal › Scientific review
- 1994
-
Mark
NIH neural transplantation funding
(
- Contribution to journal › Letter
- 1984
-
Mark
One- and two-session laser trabeculoplasty. A randomized, prospective study
(
- Contribution to journal › Article